When to discontinue venom immunotherapy: The role of retesting to venom

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 2, 2013, Pages 202-203

  Lieberman, Phillip ^a   Golden, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEE VENOM; IMMUNOGLOBULIN E; INSECT VENOM; UNCLASSIFIED DRUG; WASP VENOM; YELLOW HORNET VENOM; YELLOW JACKET VENOM;

ALLERGENICITY; ALLERGY TEST; CROSS REACTION; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; EDITORIAL; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; RADIOALLERGOSORBENT TEST; SKIN TEST; TREATMENT DURATION; VENOM HYPERSENSITIVITY; VENOM IMMUNOTHERAPY; VESPA; WASP;

ARTHROPOD VENOMS; FEMALE; HUMANS; IMMUNOTHERAPY; MIDDLE AGED; TIME FACTORS;

EID: 84877979021     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2012.12.004     Document Type: Editorial

References (9)

1. Graif Y., Confino-Cohen R., Goldberg A. Reproducibility of skin testing and serum venom-specific IgE in Hymenoptera venom allergy. Ann Allergy 2006, 96:24-29.
2. Tavares B., Rodrigues F., Pereira C., Loureiro G., Chieira C. Development of new IgE specificities to hymenoptera allergens during venom-specific immunotherapy. Eur Ann Allergy Clin Immunol 2005, 37:171-176.
3. Hamilton R.H., Wisenauer J.A., Golden D.B., Valentine M.D., Adkinson N.F. Selection of Hymenoptera venoms for immunotherapy based on patients' IgE antibody cross-reactivity. J Allergy Clin Immunol 1993, 92:651-659.
4. Muller U.R., Johansen N., Petersen A.B., Fromberg-Nielsen J., Haeberli G. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5. Allergy 2008, 64:543-548.
5. Eberlein B., Krischan L., Darsow U., Ollert M. Double positivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinants. J Allergy Clin Immunol 2012, 130:155-161.
6. Sturm G.J., Hemmer W., Hawranek T., Lang R., Ollert M., Spillner E., et al. Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergy. J Allergy Clin Immunol 2011, 128:247-248.
7. Golden D.B., Moffitt J., Nicklas R.A. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol 2011, 127:852-854. AAAAI.
8. Niedoszytko M., deMonchy J., vanDoormaal J.J., Jassem E., Oude-Elberink J.N.G. Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy. Allergy 2009, 64:1237-1245.
9. Golden D.B., Kagey-Sobotka A., Lichtenstein L.M. Survey of patients after discontinuing venom immunotherapy. J Allergy Clin Immunol 2000, 105:385-390.